Adverse Outcome Pathways: From Research to Regulation
This record is part of
a dataset collected by the EU Commission in June-September 2018
. Some of these links will therefore die out with time.
Please see the
overview of courses maintained by ETPLAS
or contact Norecopa for more information.
Owner/Developer: National Institutes of Health (NIH)
Country: |
United States of America |
---|---|
Languages: |
English |
Url: |
https://ntp.niehs.nih.gov/pubhealth/evalatm/3rs-meetings/past-meetings/aop-wksp-2014/index.html |
Locations: |
United States of America |
City: |
Bethesda, Maryland |
Description: | This workshop brought together over 100 scientists from industry, academia, U.S. and international regulatory agencies, and animal welfare groups to explore how scientific progress in adverse outcome pathway concepts can improve regulatory assessment of chemical toxicity. |
Format: |
Workshops |
Presence: |
Optional / Voluntary |
Content type: |
Theoretical, Practical |
Duration: |
3 days |
Frequency: |
One-time event |
Target audience: |
Students, Researchers, Regulators and policy-makers |
Target sectors: |
Governmental bodies, Academia, Industry |
Educational level: |
University (Doctoral education), Postdoctoral (teaching and research), Continuing Professional Development |
3rs relevance: |
Replacement |
Topics covered: |
Computational methods |
3rs coverage: |
Partial coverage (e.g. a module) |
Details on the topic or technology covered: |
AOPs Under Development Regulatory Uses for Well-Identified AOPs The Risk Context The Process of Regulatory Acceptance Using AOPs for Regulatory Decisions: Confidence and Criteria Taking Qualitative AOPs to the Next (Quantitative) |
Legislative framework: |
Test guidelines (OECD, ISO, etc.) |
Fant du det du lette etter?
Ja, jeg fant det! Nei, jeg fant det ikke!Takk for din tilbakemelding! Vær oppmerksom på at vi ikke kan kontakte deg hvis ikke du oppgir din epostadresse.
Hva lette du etter?
Gi oss gjerne en tilbakemelding slik at vi kan forbedre informasjonen på siden. På forhånd takk for hjelpen! Vennligst skriv inn din epostadresse hvis du vil ha et svar.
Kontakt oss gjerne på e-post hvis du har spørsmål.